Skip to main content
Top
Published in: Respiratory Research 1/2008

Open Access 01-12-2008 | Research

Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease

Authors: Stephan Steiner, Per O Schueller, Marcus G Hennersdorf, Dominik Behrendt, Bodo E Strauer

Published in: Respiratory Research | Issue 1/2008

Login to get access

Abstract

Rationale

There is growing evidence that obstructive sleep apnea is associated with coronary artery disease. However, there are no data on the course of coronary stenosis after percutaneous coronary intervention in patients with obstructive sleep apnea.

Objectives

To determine whether sleep apnea is associated with increased late lumen loss and restenosis after percutaneous coronary intervention.

Methods

78 patients with coronary artery disease who underwent elective percutaneous coronary intervention were divided in 2 groups: 43 patients with an apnea hypopnea – Index < 10/h (group I) and 35 pt. with obstructive sleep apnea and an AHI > 10/h (group II). Late lumen loss, a marker of restenosis, was determined using quantitative coronary angiography after 6.9 ± 3.1 months.

Main results

Angiographic restenosis (>50% luminal diameter), was present in 6 (14%) of group I and in 9 (25%) of group II (p = 0.11). Late lumen loss was significant higher in pt. with an AHI > 10/h (0.7 ± 0.69 mm vs. 0.38 ± 0.37 mm, p = 0.01). Among these 35 patients, 21(60%) used their CPAP devices regularly. There was a marginally lower late lumen loss in treated patients, nevertheless, this difference did not reach statistical significance (0.57 ± 0.47 mm vs. 0.99 ± 0.86 mm, p = 0.08). There was no difference in late lumen loss between treated patients and the group I (p = 0.206).

Conclusion

In summary, patients with OSA and coronary artery disease have a higher degree of late lumen loss, which is a marker of restenosis and vessel remodeling after elective percutaneous intervention.
Literature
1.
go back to reference Peker Y, Kraiczi H, Hedner J, Löth S, Johansson A, Bende M: An independent associationn between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999, 14:179–184.CrossRefPubMed Peker Y, Kraiczi H, Hedner J, Löth S, Johansson A, Bende M: An independent associationn between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999, 14:179–184.CrossRefPubMed
2.
go back to reference Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U: Sleep-disordered breathing and coronary artery disease: long- term prognosis. Am J Respir Crit Care Med 2001,164(10 Pt 1):1910–1913.CrossRefPubMed Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U: Sleep-disordered breathing and coronary artery disease: long- term prognosis. Am J Respir Crit Care Med 2001,164(10 Pt 1):1910–1913.CrossRefPubMed
3.
go back to reference Andreas S, Schulz R, Werner GS, Kreuzer H: Prevalence of obstructive sleep apnoea in patients with coronary artery disease. Coronary Artery Disease 1996, 7:541–545.CrossRefPubMed Andreas S, Schulz R, Werner GS, Kreuzer H: Prevalence of obstructive sleep apnoea in patients with coronary artery disease. Coronary Artery Disease 1996, 7:541–545.CrossRefPubMed
4.
go back to reference Hayashi M, Fujimoto K, Urushibata K, Uchikawa S, Imamura H, Kubo K: Nocturnal Oxygen Desaturation Correlates With the Severity of Coronary Atherosclerosis in Coronary Artery Disease. Chest 2003,124(3):936–941.CrossRefPubMed Hayashi M, Fujimoto K, Urushibata K, Uchikawa S, Imamura H, Kubo K: Nocturnal Oxygen Desaturation Correlates With the Severity of Coronary Atherosclerosis in Coronary Artery Disease. Chest 2003,124(3):936–941.CrossRefPubMed
5.
go back to reference Milleron O, Pilliere R, Foucher A, de Roquefeuil F, Aegeter P, Jondeau G, Raffestin BG, Dubourg O: Bebefits of obstructive sleep apnea ztreatment in coronary artery disease: a long term follow-up study. Eur Heart J 2004,25(9):728–734.CrossRefPubMed Milleron O, Pilliere R, Foucher A, de Roquefeuil F, Aegeter P, Jondeau G, Raffestin BG, Dubourg O: Bebefits of obstructive sleep apnea ztreatment in coronary artery disease: a long term follow-up study. Eur Heart J 2004,25(9):728–734.CrossRefPubMed
6.
go back to reference Gamis AS, Howard DE, Olson EJ, Somers VK: Day-Night pattern of sudden death in obstrcuctive sleep apnea. N Engl J Med 2005,352(12):1206–1214.CrossRef Gamis AS, Howard DE, Olson EJ, Somers VK: Day-Night pattern of sudden death in obstrcuctive sleep apnea. N Engl J Med 2005,352(12):1206–1214.CrossRef
7.
go back to reference Peker Y, Hedner J, Kraiczi, Löth S: Respiratory disturbance index. An independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000,162(1):81–86.CrossRefPubMed Peker Y, Hedner J, Kraiczi, Löth S: Respiratory disturbance index. An independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000,162(1):81–86.CrossRefPubMed
8.
go back to reference Seruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JH, ten Katen HJ, van Es GA, Hugenholtz PG: Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. A quantitative angiography study in 342 consecutive patients at 1,2,3 and 4 months. Circulation 1988,77(2):361–371.CrossRef Seruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JH, ten Katen HJ, van Es GA, Hugenholtz PG: Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. A quantitative angiography study in 342 consecutive patients at 1,2,3 and 4 months. Circulation 1988,77(2):361–371.CrossRef
9.
go back to reference Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H: Restenosis after successful percutaneous transluminal coronary angioplasty. serial angiographic follow up in 229 patients. J Am Coll Cardiol 1988,12(3):616–623.CrossRefPubMed Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H: Restenosis after successful percutaneous transluminal coronary angioplasty. serial angiographic follow up in 229 patients. J Am Coll Cardiol 1988,12(3):616–623.CrossRefPubMed
10.
go back to reference Ray S, Penn I: Intracoronary stents. In Practical interventional cardiology. Volume 12. 1st edition. Edited by: Grech ED and Ramsdale DR. London, Dunitz Martin; 1997:215–232. Ray S, Penn I: Intracoronary stents. In Practical interventional cardiology. Volume 12. 1st edition. Edited by: Grech ED and Ramsdale DR. London, Dunitz Martin; 1997:215–232.
11.
go back to reference Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H: Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 2007,99(1):26–30.CrossRefPubMed Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H: Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 2007,99(1):26–30.CrossRefPubMed
12.
go back to reference Steiner S, Jax TW, Evers S, Hennersdorf MG, Schwalen A, Strauer BE: Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 2005, 104:92–96.CrossRefPubMed Steiner S, Jax TW, Evers S, Hennersdorf MG, Schwalen A, Strauer BE: Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 2005, 104:92–96.CrossRefPubMed
13.
go back to reference Teschler H, Berthon-Jones M, Thompson AB, Henkel A, Henry J, Konietzko N: Automated continuous positive airway pressure titration for obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996, 154:734–740.CrossRefPubMed Teschler H, Berthon-Jones M, Thompson AB, Henkel A, Henry J, Konietzko N: Automated continuous positive airway pressure titration for obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996, 154:734–740.CrossRefPubMed
14.
go back to reference Gronenschild E, Janssen J, Tijdens F: CAAS II: A second generation system for off-line and on-line quantitative coronary angiography. Cathet Cardiovasc Diagn 1994,33(1):61–75.CrossRefPubMed Gronenschild E, Janssen J, Tijdens F: CAAS II: A second generation system for off-line and on-line quantitative coronary angiography. Cathet Cardiovasc Diagn 1994,33(1):61–75.CrossRefPubMed
15.
go back to reference Steiner S, Hennersdorf MG, Strauer BE: Chemoreflexsensitivity is reduced in obstructive sleep apnea and might be modulated by the autonomic system. Med Klin (Munich). 2006, 101:178–181. Steiner S, Hennersdorf MG, Strauer BE: Chemoreflexsensitivity is reduced in obstructive sleep apnea and might be modulated by the autonomic system. Med Klin (Munich). 2006, 101:178–181.
16.
go back to reference Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lücke C, Mayer K, Olschewski H, Seeger W, Grimminger F: Decreased plasma levels of nitric oxide derivates in obstructive sleep apnea: response to CPAP-Therapy. Thorax 2000,55(12):1046–1051.CrossRefPubMedPubMedCentral Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lücke C, Mayer K, Olschewski H, Seeger W, Grimminger F: Decreased plasma levels of nitric oxide derivates in obstructive sleep apnea: response to CPAP-Therapy. Thorax 2000,55(12):1046–1051.CrossRefPubMedPubMedCentral
17.
go back to reference Duchna HW, Guilleminault C, Stoohs RA, Faul JL, Moreno H, Hoffman BB, Blaschke TF: Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2000,161(1):187–191.CrossRefPubMed Duchna HW, Guilleminault C, Stoohs RA, Faul JL, Moreno H, Hoffman BB, Blaschke TF: Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2000,161(1):187–191.CrossRefPubMed
18.
go back to reference Hamiliton GS, Solin P, Naughton MT: Obstructive sleep apnoea and cardiovascular disease. Intern Med J 2004, 34:420–426.CrossRef Hamiliton GS, Solin P, Naughton MT: Obstructive sleep apnoea and cardiovascular disease. Intern Med J 2004, 34:420–426.CrossRef
19.
go back to reference Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A: Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervetion. J Am Coll Cardiol 2008, 50:1310–1314.CrossRef Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A: Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervetion. J Am Coll Cardiol 2008, 50:1310–1314.CrossRef
20.
go back to reference Foley DP, Serruys PW: The changing face of restenosis. In Practical interventional cardiology. Volume 14. 1st edition. Edited by: Grech ED and Ramsdale DR. London, Martin Dunitz Ltd.; 1997:249–268. Foley DP, Serruys PW: The changing face of restenosis. In Practical interventional cardiology. Volume 14. 1st edition. Edited by: Grech ED and Ramsdale DR. London, Martin Dunitz Ltd.; 1997:249–268.
21.
go back to reference Hayashi M, Fujimoto K, Urushibata K, Imamura H, Kinoshita O, Kubo K: Nocturnal oxygen desaturation as a predictive risk factor for coronary restenosis after coronary intervention - serial quantitative coronary angiography study-. Circ J 2005, 69:1320–1326.CrossRefPubMed Hayashi M, Fujimoto K, Urushibata K, Imamura H, Kinoshita O, Kubo K: Nocturnal oxygen desaturation as a predictive risk factor for coronary restenosis after coronary intervention - serial quantitative coronary angiography study-. Circ J 2005, 69:1320–1326.CrossRefPubMed
22.
go back to reference Toutouzas K, Colombo A, Stefanidis C: Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 2004,25(19):1679–1687.CrossRefPubMed Toutouzas K, Colombo A, Stefanidis C: Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 2004,25(19):1679–1687.CrossRefPubMed
23.
go back to reference Shamsuzzaman ASM, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK: Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea. Circulation 2002,105(21):2462–2464.CrossRefPubMed Shamsuzzaman ASM, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK: Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea. Circulation 2002,105(21):2462–2464.CrossRefPubMed
24.
go back to reference Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003,107(8):1129–1134.CrossRefPubMed Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003,107(8):1129–1134.CrossRefPubMed
25.
go back to reference Svatikova A, Wolk R, Shamsuzzaman AS, Kara T, Olson EJ, Somers VK: Serum amyloid A in obstrictive sleep apnea. Circulation 2003,108(12):1451–1454.CrossRefPubMed Svatikova A, Wolk R, Shamsuzzaman AS, Kara T, Olson EJ, Somers VK: Serum amyloid A in obstrictive sleep apnea. Circulation 2003,108(12):1451–1454.CrossRefPubMed
26.
go back to reference Loube DI, Gay PC, Strohl KP, Pack AI, White DP, Collop NA: Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest 1999,115(3):863–866.CrossRefPubMed Loube DI, Gay PC, Strohl KP, Pack AI, White DP, Collop NA: Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest 1999,115(3):863–866.CrossRefPubMed
27.
go back to reference Duchna HW, Grote L, Sndreas S, Schulz R, Wessendorf T, Becker HF, Clarenbach P, Fietze I, Hein H, Koehler U, Nachtmann A, Randerath W, Rasche K, Rühle KH, Sanner B, Schäfer H, Staats R, Töpfer V: Sleep disordered breathing and cardio- and cerebrovascular diseases: 2003 update of clinical significance and future perspectives. Somnologie 2003, 7:121.CrossRef Duchna HW, Grote L, Sndreas S, Schulz R, Wessendorf T, Becker HF, Clarenbach P, Fietze I, Hein H, Koehler U, Nachtmann A, Randerath W, Rasche K, Rühle KH, Sanner B, Schäfer H, Staats R, Töpfer V: Sleep disordered breathing and cardio- and cerebrovascular diseases: 2003 update of clinical significance and future perspectives. Somnologie 2003, 7:121.CrossRef
28.
go back to reference Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, O`Connor GT, Boland LL, Schwartz JE, Samet JM, e AMET, jm: Sleep-disoredered breathing and cardiovascular disease. Cross sectional results of the sleep heart health study. Am J Respir Crit Care Med 2001, 163:19–25.CrossRefPubMed Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, O`Connor GT, Boland LL, Schwartz JE, Samet JM, e AMET, jm: Sleep-disoredered breathing and cardiovascular disease. Cross sectional results of the sleep heart health study. Am J Respir Crit Care Med 2001, 163:19–25.CrossRefPubMed
29.
go back to reference Sampol G, Rodes G, Romero O, Jurado MJ, Lloberes P: Adherence to nCPAP in patients with coronary artery disease and sleep apnea without sleepiness. Respir Med 2007,101(3):461–466.CrossRefPubMed Sampol G, Rodes G, Romero O, Jurado MJ, Lloberes P: Adherence to nCPAP in patients with coronary artery disease and sleep apnea without sleepiness. Respir Med 2007,101(3):461–466.CrossRefPubMed
Metadata
Title
Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease
Authors
Stephan Steiner
Per O Schueller
Marcus G Hennersdorf
Dominik Behrendt
Bodo E Strauer
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2008
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-9-50

Other articles of this Issue 1/2008

Respiratory Research 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine